Cyclooxygenase-2 Biology
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
2177-2190
Author(s):
Joan Claria
The Stress Response: Implications for the Clinical Development of Hsp90 Inhibitors
Journal:
Current Cancer Drug Targets
Volume:
3
Page:
349-358
Author(s):
Luke Whitesell, Rochelle Bagatell and Ryan Falsey
Anticonvulsant Activity Of Benzylamides Of Some Amino Acids And Heterocyclic Acids
Journal:
Protein & Peptide Letters
Volume:
10
Page:
475-482
Author(s):
Ryszard Paruszewski, Marzanna Strupinska, Grazyna Rostafinska-Suchar and James P. Stables
Cardiotoxic and Antiarrhythmic Tertiary Amine Local Anesthetics: Sodium Channel Affinity vs. Sodium Channel Gating
Journal:
Current Vascular Pharmacology
Volume:
1
Page:
239-242
Author(s):
Sterling N. Wright
Role of Endothelin in Diabetic Retinopathy
Journal:
Current Vascular Pharmacology
Volume:
1
Page:
243-250
Author(s):
Hing-Chung Lam, Jenn-Kuen Lee, Chih-Chen Lu, Chih-Hsun Chu, Ming-Ju Chuang and Mei-Chun Wang
ATP-Sensitive K+ Channel Openers: Old Drugs with New Clinical Benefits for the Heart
Journal:
Current Vascular Pharmacology
Volume:
1
Page:
251-258
Author(s):
Tetsuji Miura and Takayuki Miki
Low-Molecular-Weight Heparins in Acute Coronary Syndromes
Journal:
Current Vascular Pharmacology
Volume:
1
Page:
259-271
Author(s):
Mehmet E. Korkmaz
Therapeutic Value of Statins for Vascular Remodeling
Journal:
Current Vascular Pharmacology
Volume:
1
Page:
273-279
Author(s):
Hirotaka Nagashima and Hiroshi Kasanuki
Endothelin Receptor Antagonists: A New Therapeutic Option for Improving the Outcome after Solid Organ Transplantation?
Journal:
Current Vascular Pharmacology
Volume:
1
Page:
281-299
Author(s):
Uwe Gottmann, Fokko J. van der Woude and Claude Braun
Cannabinoid System as a Potential Target for Drug Development in the Treatment of Cardiovascular Disease
Journal:
Current Vascular Pharmacology
Volume:
1
Page:
301-313
Author(s):
Victoria E. Mendizabal and Edda Adler-Graschinsky